IFNG and infection: Additionally, “hybrid immunity” elicits cross-reactive CD8+ T-cell responses against Omicron variants and enhances the release of IFN-γ and IL-10 by virus-specific CD4+ T cells, thereby inhibiting infection-induced inflammation progression (69, 70).